A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

491

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

May 16, 2018

Study Completion Date

May 16, 2018

Conditions
Binge Eating Disorder
Interventions
DRUG

dasotraline 4mg

dasotraline 4mg tablet once daily

DRUG

dasotraline 6mg

dasotraline 6mg tablet once daily

DRUG

Placebo

Placebo tablet once daily

Trial Locations (50)

10036

Manhattan Behavior Medicine, New York

10128

The Medical Research Network, LLC, New York

10549

Bioscience Research, LLC, Mount Kisco

18104

Lehigh Center for Clinical Research, Allentown

27612

Wake Research Associates, Raleigh

29464

Costal Carolina Research Center, Mt. Pleasant

29650

Radiant Research, Greer

30060

Northwest ehavioral Research Center, Marietta

30341

Institute for Advanced Medical Research at Mercer University, Atlanta

30342

Neurotrials Research, Inc., Atlanta

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

33143

Miami Research Associates, South Miami

33912

Gulfcoast Clinical Research Center, Fort Myers

37203

Clinical Research Associates, Inc, Nashville

38119

Clinical Neuroscience Solutions, Inc., Memphis

44311

Radient Research, Akron

45040

Linder Center of Hope, Mason

45215

Patient Priority Clinical Sites, LLC, Cincinnati

45417

Midwest Clinical Research Center, Dayton

48307

Rocheser Center for Behavioral Medicine, Rochester Hills

60048

Capstone Clinical Research, Libertyville

63304

Midwest Research Group - St. Charles Psychiatric Associates, Saint Charles

66208

Phoenix Medical Research, Inc., Prairie Village

67206

Prairie Health and Wellness, Wichita

75080

Pillar Clinical Research, Richardson

77081

Texas Center for Drug Development, Inc, Houston

78229

Clinical Trials of Texas, Inc, San Antonio

Radiant Research, Inc., San Antonio

78737

Donald J. Garcia, MD, PA, Austin

80209

Lytle and Weiss PLLC, Denver

80910

MCB Clinical Research Centers, LLC, Colorado Springs

84123

Radiant Research, Inc., Murray

85032

NoesisPharma, LLC, Phoenix

90210

Southern California Research, Beverly Hills

91316

Pharmacology Research Institute, Encino

92108

PCSD- Feighner Research, San Diego

92660

Pharmacology Research Institute, Newport Beach

92705

Syrentis Clinical Research, Santa Ana

92708

Artemis Institute for Clinical Research, San Marcos

92845

Collaborative NeuroScience Network, LLC, Garden Grove

97214

Oregon Center for Clinical Investigations, Inc., Portland

97301

Oregon Center for Clinical Investigations, Inc., Salem

06416

Connecticut Clinical Research, Cromwell

02478

McLean Hospital Harvard Medical School, Belmont

02131

Boston Clinical Trials, Boston

01844

ActivMed Practices and Research, Inc, Methuen

02472

Adams Clinical Trials, LLC, Watertown

03801

ActivMed Practice and Research, Inc, Portsmouth

08002

Center for Emotional Fitness, Cherry Hill

05091

Neuropsychiatric Associates, Woodstock

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT03107026 - A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder | Biotech Hunter | Biotech Hunter